HLB GLOBAL Co., Ltd. (KRX:003580)
1,573.00
-7.00 (-0.44%)
At close: Aug 21, 2026
HLB GLOBAL Revenue
HLB GLOBAL had revenue of 31.16B KRW in the quarter ending June 30, 2026, with 15.23% growth. This brings the company's revenue in the last twelve months to 107.08B, up 17.63% year-over-year. In the year 2025, HLB GLOBAL had annual revenue of 100.29B with 7.90% growth.
Revenue (ttm)
107.08B
Revenue Growth
+17.63%
P/S Ratio
0.75
Revenue / Employee
713.85M
Employees
150
Market Cap
79.89B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.29B | 7.34B | 7.90% |
| Dec 31, 2024 | 92.94B | 13.08B | 16.37% |
| Dec 31, 2023 | 79.87B | 35.27B | 79.10% |
| Dec 31, 2022 | 44.59B | -454.25M | -1.01% |
| Dec 31, 2021 | 45.05B | 9.67B | 27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KG Chemical | 9.37T |
| Kolon | 5.99T |
| HS HYOSUNG | 1.41T |
| Woongjin | 1.28T |
| Hyundai Futurenet | 277.25B |
| Singsong Holdings | 193.46B |
| Aprogen Medicines | 127.54B |
| Gridwiz | 118.82B |